Cryo-Cell Q3 revenue $8.07M, net income $1.05M; strategic review ongoing, spinoff on hold

CRYO CELL INTERNATIONAL INC

2024-Q3 EPS reported $0.27 revenue$23,961,761

Revenue $8.07M vs $7.87M YoY; net income $1.05M ($0.13/diluted) vs $0.68M ($0.08).
Gains on marketable securities $522k vs $93k YoY, boosting earnings.
Company exploring strategic alternatives to maximize shareholder value; process ongoing.
Spinoff of Celle Corp on hold due to arbitration demand with Duke University (see Form 10-Q).
Board considering instituting regular quarterly dividend; no decision yet.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.